1.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 65 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20-03-001, NCT00106392
|
|
2.
|
Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684
|
|
3.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor:
Protocol IDs: WSU-Z-1093-93, NCI-V94-0363
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor: Other
Protocol IDs: FHCRC-949.00, NCI-V95-0776
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 55
Sponsor: NCI
Protocol IDs: MDA-DM-94106, NCI-G96-1008
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI
Protocol IDs: COG-ASCT0031, CCG-S9701, NCI-P02-0213, ASCT0031, NCT00031824
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000258113, ECOG-1900, NCT00049517
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: Under 22
Sponsor: NCI
Protocol IDs: COG-ASCT0631, ASCT0631, COG-PBMTC-STC051, NCT00450450
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 to 55
Sponsor: NCI
Protocol IDs: MDA-DM-94064, NCI-G96-0999, NCT00002831
|
|
11.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 12472, ACHE, NCT00056966
|
|
12.
|
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: ID00-132, NCT00506922
|
|
13.
|
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: CDR0000378004, FHCRC-1811.00, NCT00089037
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 17 to 60
Sponsor: Other
Protocol IDs: TUHSC-2803, NCI-V96-0950, NCT00002809
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 50
Sponsor: NCI
Protocol IDs: MDA-DM-95093, NCI-V96-1004
|
|
16.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 12 to 50
Sponsor: NCI
Protocol IDs: MDA-DM-93120, NCI-G96-1007
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 to 55
Sponsor: NCI
Protocol IDs: MDA-DM-95095, NCI-V96-1016
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: JHOC-98070603, JHOC-9845, NCI-H98-0023, NCT00003572
|
|
19.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 50 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000067538, UCLA-9905097, CCT-C99-101, NCI-G00-1672, NCT00004878
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: MSGCC-0012, NCI-V00-1624, NCT00006350
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 60
Sponsor: NCI
Protocol IDs: CLB-59908, NCT00006747, CALGB-59908
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Under 60 (over 60 requires review)
Sponsor: NCI
Protocol IDs: MSKCC-00126, NCI-H01-0070, NCT00014469
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: FCCC-01006, TUHSC-3721, NCI-G01-2021, NCT00025519
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and under
Sponsor: NCI
Protocol IDs: CALGB-90003, ECOG-CALGB-C90003, SWOG-CALGB-C90003, NCT00027573
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 65
Sponsor: NCI
Protocol IDs: CALGB-100001, NCT00028600
|
